First in vitro studies on using gas plasma technology were conducted more than a decade ago in T89G cells, showing jet plasma inhibitory effects on GBM growth and clonogenicity [309], which was suggested to be regulated via AKT1 and ERK1/2 signaling [310] in gas plasma-treated GBM cells. The gene discussed is AKT1; the disease is glioblastoma.